Intellia Therapeutics is trading at $12.62, up 6.62% in after-hours trading; no verified company announcement or clearly linked catalyst for the October 20 move was found.
- The latest company press release located was dated October 13.
- The appointment announcement and FDA priority-review news are earlier developments, not confirmed explanations for this move.
- After-hours volume and activity details were unavailable in the provided price context.